A detailed history of Seaport Global Advisors, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Seaport Global Advisors, LLC holds 6,337 shares of EXAS stock, worth $287,256. This represents 0.9% of its overall portfolio holdings.

Number of Shares
6,337
Previous 24,619 74.26%
Holding current value
$287,256
Previous $1.82 Million 76.0%
% of portfolio
0.9%
Previous 4.38%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$56.27 - $73.77 $1.03 Million - $1.35 Million
-18,282 Reduced 74.26%
6,337 $437,000
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $1.45 Million - $1.86 Million
24,619 New
24,619 $1.82 Million
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $476,078 - $682,688
-8,271 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $599,647 - $832,724
8,271 New
8,271 $644,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.02B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Seaport Global Advisors, LLC Portfolio

Follow Seaport Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seaport Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seaport Global Advisors, LLC with notifications on news.